Immunohistochemical characteristics of breast cancer in Kazakh and Russian populations

2009

Closed access Metadata (CSL-JSON)
DOI 10.1200/jco.2009.27.15_suppl.e22162
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

e22162 Background: Ethnic differences of breast cancer were satisfactory investigated in different populations of the United States and some important findings were revealed. In other areas of the world amount of similar studies is relatively low. Our aim was to investigate the ethnical differences in the expression of standard immunohistochemical markers of breast cancer between two main nations of Kazakhstan and to reveal possible correlations between these markers and prognosis of the patients. Methods: 664 breast cancer patients, treated in Karaganda Regional Cancer Center during 2006–2007, were included in this study (222 patients of Kazakh population and 442 patients of Russian population). Immunohistochemical expression of estrogen and progesterone receptors (ER and PR) and Her2/neu was determined in all patients. Expression of steroid receptors was counted as positive if staining was presented in more than one percent of breast cancer cells. Her2/neu expression was divided in two groups: 0, 1+ - negative expression, 2+, 3+ - positive expression. The obtained data was calculated and processed by statistical program - Statistica 6.0. Results: Breast cancer in Kazakh patients demonstrated higher level of Her2/neu positive expression (31.5% versus 23.8, p<0.05) and lower level of isolated ER and PR expression (36.5 versus 44.3, p=0.05). Still, breast cancer in Russian patients was more frequently associated with basal phenotype (15.2 versus 9.5, p<0.05).Strong inverse correlation was observed between age of patients and Her2/neu status (p=0.0005) and direct correlation between age and positive expression of steroid receptors (p<0.05). These correlations were observed in both populations. Conclusions: Breast cancer in Kazakh population was statistically significantly associated with unfavorable prognostic and predictive immunohistochemical status, such as higher expression of Her2/neu and lower expression of steroid receptors. Nevertheless elder patients were more likely to have less aggressive disease, independently from population. No significant financial relationships to disclose.